Home > Food & Beverages > Nutraceuticals > Protein Supplements > Chondroitin Market

Chondroitin Market Size - By Source (Bovine, Synthetic, Shark, Swine, Others), By Form (Capsules, Tablet, Powder), By Application (Nutraceuticals, Pharmaceuticals, Personal Care & Cosmetics, Animal Feed, Others) & Forecast, 2024 – 2032

  • Report ID: GMI3461
  • Published Date: Mar 2024
  • Report Format: PDF

Chondroitin Market Size

Chondroitin Market size was valued at USD 1.28 billion in 2023 and is anticipated to register a CAGR of over 3.8% between 2024 and 2032. The market encompasses the segment of bovine witnessing a surge in demand across various industries owing to its versatile applications. Primarily, bovine cartilage is rich in chondroitin sulfate, making it a cost-effective and abundant source of this compound. Secondly, bovine chondroitin is chemically like human chondroitin, enhancing its effectiveness in dietary supplements and pharmaceuticals. Thirdly, bovine chondroitin extraction processes are well-established and yield high-quality products.

Chondroitin Market

Additionally, bovine-derived chondroitin meets regulatory standards and is widely accepted in the pharmaceutical and nutraceutical industries. Its availability in large quantities from beef processing industries further contributes to its dominance in the chondroitin market. Lastly, its relatively lower cost compared to other sources makes it a preferred option for manufacturers and consumers alike.

Moreover, a significant driver influencing the dominance of bovine-derived chondroitin in the market is its perceived efficacy and safety. Studies and consumer perception often favor bovine-derived chondroitin for its perceived bioavailability and effectiveness in managing joint health issues. Furthermore, advancements in extraction and purification technologies have enhanced the safety profile of bovine-derived chondroitin, addressing concerns regarding contamination or allergenicity. This assurance of safety, coupled with its established efficacy, continues to drive the demand for bovine-derived chondroitin in the market, solidifying its dominant position, thus the market is expected to witness sustained growth in the coming years.

Price fluctuations in raw materials, such as bovine and shark cartilage, are exerting significant pressure on the affordability of products in the chondroitin market. These fluctuations are largely influenced by factors like environmental regulations, supply chain disruptions, and shifts in consumer demand. As a result, manufacturers are facing challenges in maintaining stable pricing for Chondroitin supplements and pharmaceuticals.

The volatility in raw material costs directly impacts production costs, subsequently affecting the final retail prices. This situation poses a dilemma for both producers and consumers, leading to uncertainties in market dynamics and potential shifts in purchasing patterns. To mitigate these challenges, industry players are exploring alternative sources for Chondroitin production and implementing strategies to optimize supply chains and manage costs effectively. However, the persistent instability in raw material prices continues to pose a significant barrier to ensuring affordability in the market.

Chondroitin Market Trends

In recent years, increasing consumer awareness about joint supplements, particularly those containing chondroitin, is driving the market. Consumers are becoming more informed about the benefits of chondroitin in promoting joint health and managing conditions like osteoarthritis. This heightened awareness is fueled by widespread access to information through various channels such as online resources, social media, and healthcare professionals.

As a result, there's a growing demand for chondroitin supplements among aging populations and individuals seeking natural remedies for joint-related issues. This trend not only reflects a shift towards proactive health management but also presents lucrative opportunities for manufacturers and retailers in the market.

Furthermore, the chondroitin market is experiencing a surge in demand for natural and sustainable ingredients, driven by growing consumer preferences for health-conscious products. This shift is influenced by increasing awareness of the benefits of natural supplements and concerns about environmental sustainability. Consumers are actively seeking chondroitin sourced from eco-friendly and ethically produced raw materials, such as plant-based sources or sustainably harvested marine sources.


Manufacturers are responding to this trend by investing in research and development to innovate sustainable production methods and sourcing practices. As a result, products containing natural and sustainable chondroitin ingredients are gaining traction in the market, attracting environmentally conscious consumers, and driving overall market growth. This demand for natural and sustainable ingredients acts as a significant driver, boosting the market and shaping its future trajectory towards more environmentally friendly practices and offerings.


Chondroitin Market Analysis

Chondroitin Market Size, By Sources, 2021 - 2032 (USD Billion)

Based on sources, the market is divided into bovine, synthetic, shark, swine, and others. The bovine source segment dominated around USD 560 million revenue in 2023. In the chondroitin market, bovine plays a significant role due to its widespread availability and cost-effectiveness compared to other sources. Bovine Chondroitin finds extensive applications across various end-user industries, including pharmaceuticals, dietary supplements, and cosmetics.

In pharmaceuticals, it is utilized for treating osteoarthritis and joint-related ailments. In dietary supplements, bovine chondroitin is popular for promoting joint health and mobility. Additionally, it is a common ingredient in cosmetic products, renowned for its moisturizing and anti-aging properties. The versatility, affordability, and efficacy of bovine-derived Chondroitin make it the preferred choice for manufacturers catering to these industries, contributing to its dominance in the market.

Chondroitin Market Revenue Share, By Form, (2023)

Based on form, the market is categorized as capsule, tablet, powder. The capsule form segment accounted for 45% of the chondroitin market share in 2023. capsules offer convenient and precise dosing, making them popular among consumers seeking Chondroitin supplements for joint health and mobility. Capsules also provide an easy-to-swallow form factor, enhancing consumer compliance with recommended dosages. Furthermore, capsules offer excellent protection for sensitive Chondroitin ingredients, minimizing degradation and ensuring product efficacy over time.

Additionally, capsules allow for customization and combination with other beneficial ingredients, catering to specific consumer preferences and health needs. The convenience, efficacy, and flexibility offered by capsules position them as the preferred delivery form in the Chondroitin market, driving their dominance in this segment.

Based on application, the market is categorized as nutraceuticals, pharmaceuticals, personal care & cosmetics, animal feed, and others. In nutraceuticals, there's a growing consumer awareness and preference for natural and holistic approaches to health and wellness, driving demand for Chondroitin supplements as part of nutraceutical products. The aging population, particularly in developed countries, is seeking solutions for joint health and mobility, making Chondroitin a vital component in nutraceutical formulations targeting this demographic.

Moreover, the ease of access and convenience offered by nutraceutical products, such as Chondroitin capsules or powders, align well with modern consumer lifestyles, further propelling their dominance in the market. Additionally, with increasing research supporting the efficacy of Chondroitin in improving joint function and relieving arthritis symptoms, nutraceutical companies are focusing on developing innovative formulations to meet this demand, solidifying their position as leaders in the market.

North America Chondroitin Market Size, 2021- 2032 (USD Million)

North America chondroitin market generated a revenue of USD 500 million in 2023. One key reason is its large and mature healthcare sector, which fosters high levels of consumer awareness about joint health. Additionally, the region's significant aging population drives demand for Chondroitin-based products, given its perceived benefits for joint health and mobility. North America also boasts a strong network of pharmaceutical and nutraceutical companies that produce and distribute Chondroitin supplements and pharmaceuticals.

Furthermore, stringent regulatory standards ensure product quality and safety, enhancing consumer trust in Chondroitin products. The region's robust distribution channels and extensive retail presence further facilitate accessibility to Chondroitin supplements, contributing to its dominance in the market.

Chondroitin Market Share

Chondroitin Market Company Share, (2023)

AdvaCare Pharma, BASIC NUTRITION, Beloor Bayir., Bioiberica S.A.U., Inc. and Chongqing Aoli Biopharmaceutical Co. Ltd collectively dominate the chondroitin industry with their extensive industry experience, innovative product offerings, and widespread global presence. AdvaCare Pharma is a leading global manufacturer and supplier of high-quality Chondroitin products, catering to pharmaceutical and nutraceutical markets worldwide.

Renowned for its commitment to quality and innovation, AdvaCare Pharma offers a diverse range of Chondroitin formulations to meet various consumer needs. Basic nutrition for Chondroitin involves a balanced diet rich in sources of collagen, such as bone broth, fish, and poultry, to support joint health. Additionally, consuming foods high in vitamins C and D, as well as omega-3 fatty acids, can enhance the effectiveness of Chondroitin supplementation.

Beloor Bayir is a prominent manufacturer and supplier of Chondroitin, offering high-quality Chondroitin sulfate sourced from bovine cartilage for various pharmaceutical and nutraceutical applications worldwide. Their products adhere to stringent quality standards, ensuring efficacy and safety for consumers. Bioiberica S.A.U. is a leading global supplier of Chondroitin, known for its high-quality and sustainable sourcing practices, catering to pharmaceutical, nutraceutical, and cosmetic industries worldwide. Chongqing Aoli Biopharmaceutical Co. Ltd, further solidifying its position as a key player in the market.

These market leaders collectively shape the competitive landscape of the chondroitin market, driving innovation, setting industry standards, and meeting the evolving demands of customers worldwide. With their focus on research and development, technological advancements, and strategic partnerships, these companies continue to expand their market share and strengthen their foothold in key regions. Their relentless pursuit of excellence, coupled with their customer-centric approach, positions them as preferred suppliers of chondroitin, contributing significantly to the growth and development of the global construction industry.

Chondroitin Market Companies

Major companies operating in the chondroitin industry include:

  • AdvaCare Pharma
  • Beloor Bayir.
  • Bioiberica S.A.U.
  • Chongqing Aoli Biopharmaceutical Co. Ltd
  • Pacific Rainbow International, Inc.
  • Summit Nutritionals International
  • Synutra Pure, Ltd.
  • TSI Group Ltd.

Chondroitin Industry News

  • In March 2022, Bioiberica S.A.U partnered with ByHealth in China to meet the consumer's needs for innovative, low-dose joint health solutions.
  • In February 2022, Sigma Aldrich Inc acquired Exelead and plans to invest more than USD 600 million for technology scale-up.

The chondroitin market research report includes in-depth coverage of the industry, with estimates & forecast in terms of revenue and volume (USD Billion) (Kilo Tons) from 2018 to 2032, for the following segments:

Click here to Buy Section of this Report

Market, By Sources

  • Bovine
  • Synthetic
  • Shark
  • Swine
  • Others

Market, By Form

  • Capsules
  • Tablet
  • Powder

Market, By Application

  • Nutraceuticals
  • Pharmaceuticals
  • Personal Care & Cosmetics
  • Animal Feed
  • Others

The above information is provided for the following regions and countries:

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • UK
    • France
    • Italy
    • Spain
    • Rest of Europe
  • Asia Pacific
    • China
    • India
    • Japan
    • South Korea
    • Australia
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Argentina
    • Rest of Latin America
  • MEA
    • Saudi Arabia
    • UAE
    • South Africa
    • Rest of MEA


Authors: Kiran Pulidindi, Kunal Ahuja

Frequently Asked Questions (FAQ) :

The market size of chondroitin reached USD 1.28 billion in 2023 and is set to witness 3.8% CAGR from 2024 to 2032, owing to its availability in large quantities from beef processing industries and relatively lower cost compared to other sources worldwide.

The bovine segment recorded USD 560 million in 2023, due to its widespread availability and cost-effectiveness compared to other sources.

North America market held over USD 500 billion in 2023, attributed to its large and mature healthcare sector, which fosters high levels of consumer awareness about joint health in the region.

Beloor Bayir., Bioiberica S.A.U., Chongqing Aoli Biopharmaceutical Co. Ltd, INTER FARMA, Pacific Rainbow International, Inc., SEIKAGAKU CORPORATION, Summit Nutritionals International, Synutra Pure, Ltd., and TSI Group Ltd., are some of the major chondroitin companies worldwide.

Chondroitin Market Scope

Buy Now

Premium Report Details

  • Base Year: 2023
  • Companies covered: 10
  • Tables & Figures: 400
  • Countries covered: 22
  • Pages: 300
 Download Free Sample